{"id":879,"date":"2013-06-01T12:00:00","date_gmt":"2013-06-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2013\/serotonin-syndrom-als-additive-wechselwirkung-unter-fentanyl"},"modified":"2022-03-17T14:12:42","modified_gmt":"2022-03-17T13:12:42","slug":"serotonin-syndrom-als-additive-wechselwirkung-unter-fentanyl","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2013\/serotonin-syndrom-als-additive-wechselwirkung-unter-fentanyl","title":{"rendered":"Serotonin-Syndrom als additive Wechselwirkung unter Fentanyl"},"content":{"rendered":"<p>Der Neurotransmitter Serotonin moduliert im zentralen Nervensystem die Aufmerksamkeit, die Thermoregulation und das allgemeine Verhalten. Im peripheren Nervensystem f\u00f6rdert Serotonin die gastrointestinale Motilit\u00e4t sowie die Kontraktion der glatten Muskulatur in Blutgef\u00e4\u00dfen, Bronchien und Uterus (1). Werden periphere und zentrale Serotonin-Rezeptoren \u00fcberstimuliert, kann sich ein Serotonin-Syndrom entwickeln (2). Das Serotonin-Syndrom \u00e4u\u00dfert sich in einer neuro-exzitatorischen Trias, [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Der Neurotransmitter Serotonin moduliert im zentralen Nervensystem die Aufmerksamkeit, die Thermoregulation und das allgemeine Verhalten. Im peripheren Nervensystem f\u00f6rdert Serotonin die gastrointestinale Motilit\u00e4t sowie die Kontraktion der glatten Muskulatur in Blutgef\u00e4\u00dfen, Bronchien und Uterus (1). Werden periphere und zentrale Serotonin-Rezeptoren \u00fcberstimuliert, kann sich ein Serotonin-Syndrom entwickeln (2). Das Serotonin-Syndrom \u00e4u\u00dfert sich in einer neuro-exzitatorischen Trias, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2280,916,397,2055,2052,1613,920,391,761,968,19,2281,925,334,922,2282,2279,381,900,902,2049,378,2050,375,903,377,328,1737,578,575,379,1044],"class_list":["post-879","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-5-hydroxytryptamin-rezeptor-agonisten","tag-antidepressiva","tag-citalopram","tag-clomipramin","tag-escitalopram","tag-fentanyl","tag-fluoxetin","tag-fluvoxamin","tag-imipramin","tag-linezolid","tag-methadon","tag-milnacipran","tag-moclobemid","tag-ondansetron","tag-paroxetin","tag-pethidin","tag-rotigotin","tag-selektive-serotonin-wiederaufnahme-hemmer","tag-serotonin-noradrenalin-wiederaufnahme-hemmer","tag-serotonin-norepinephrin-wiederaufnahme-hemmer","tag-serotonin-syndrom","tag-serotonin-wiederaufnahme-hemmer","tag-serotoninsyndrom","tag-sertralin","tag-snri","tag-ssri","tag-tramadol","tag-triptane","tag-valproat","tag-valproinsaeure","tag-venlafaxin","tag-wechselwirkungen"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=879"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/879\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}